APLS APELLIS PHARMACEUTICALS INC

Ownership history in Deep Track Capital, LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.09% (2024 Q4)
Avg. % of fund
3.7%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 7,750,000 -250,382 -3.1% 3.47% $194.7M $25.12
2025 Q3 ADDED 8,000,382 +1,000,382 +14.3% 5.05% $181.0M $22.63
2025 Q2 ADDED 7,000,000 +2,000,000 +40.0% 3.89% $121.2M $17.31
2025 Q1 ADDED 5,000,000 +725,079 +17.0% 3.54% $109.3M $21.87
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)
← Back to Deep Track Capital, LP Holdings